Low levels of IgM antibodies to phosphorylcholine predict cardiovascular disease in 60-year old men: effects on uptake of oxidized LDL in macrophages as a potential mechanism.
about
Protective natural autoantibodies to apoptotic cells: evidence of convergent selection of recurrent innate-like clonesImmunoglobulin (Ig)M antibodies against oxidized cardiolipin but not native cardiolipin are novel biomarkers in haemodialysis patients, associated negatively with mortalitySelection of apoptotic cell specific human antibodies from adult bone marrowImmunity, atherosclerosis and cardiovascular diseaseLow levels of a natural IgM antibody are associated with vein graft stenosis and failure.IgM antibodies to oxidized phosphatidylserine as protection markers in cardiovascular disease among 60-year olds.Recognition of Porphyromonas gingivalis gingipain epitopes by natural IgM binding to malondialdehyde modified low-density lipoprotein.IgM-antibodies against phosphorylcholine in mothers and normal or low birth weight term newborn infants.Low levels of IgM antibodies to oxidized cardiolipin increase and high levels decrease risk of cardiovascular disease among 60-year olds: a prospective studyIncreased prevalence of vulnerable atherosclerotic plaques and low levels of natural IgM antibodies against phosphorylcholine in patients with systemic lupus erythematosusEarly inflammatory markers are independent predictors of cardiac allograft vasculopathy in heart-transplant recipients.Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer's diseaseMetabolomics and partial least square discriminant analysis to predict history of myocardial infarction of self-claimed healthy subjects: validity and feasibility for clinical practice.Cardiovascular co-morbidity in patients with rheumatic diseases.Relationships of plasma factor VIIa-antithrombin complexes to manifest and future cardiovascular disease.Atherosclerosis and rheumatoid arthritis: more than a simple association.IgM autoantibodies to distinct apoptosis-associated antigens correlate with protection from cardiovascular events and renal disease in patients with SLE.The link between antibodies to OxLDL and natural protection against pneumococci depends on D(H) gene conservation.Immune mechanisms in atherosclerosis, especially in diabetes type 2Athletes with higher VO2max present reduced oxLDL after a marathon raceHuman IgM Antibodies to Malondialdehyde Conjugated With Albumin Are Negatively Associated With Cardiovascular Disease Among 60-Year-Olds.Senescent cells expose and secrete an oxidized form of membrane-bound vimentin as revealed by a natural polyreactive antibody.Auto-antibodies as emergent prognostic markers and possible mediators of ischemic cardiovascular diseases.Future potential biomarkers for postinterventional restenosis and accelerated atherosclerosis.Protective autoantibodies in the rheumatic diseases: lessons for therapy.Prediction and management of cardiovascular outcomes in systemic lupus erythematosus.The human counterpart of mouse B-1 cells.In old BALB/c mice, bone marrow pre-B cell and surrogate light chain reduction is associated with increased B cell reactivity to phosphorylcholine, but reduced T15 idiotype dominance.IgM phosphorylcholine antibodies inhibit cell death and constitute a strong protection marker for atherosclerosis development, particularly in combination with other auto-antibodies against modified LDLFundamental roles of the innate-like repertoire of natural antibodies in immune homeostasis.Passive immunization with hypochlorite-oxLDL specific antibodies reduces plaque volume in LDL receptor-deficient mice.Low levels of natural IgM antibodies against phosphorylcholine are independently associated with vascular remodeling in patients with coronary artery disease.A role for autoantibodies in atherogenesis.Antibodies against Phosphorylcholine among New Guineans Compared to Swedes: An Aspect of the Hygiene/Missing Old Friends Hypothesis.Autoantibodies to phosphorylcholine and cardiovascular outcomes in patients with acute coronary syndromes in the ATLAS ACS-TIMI 46 trial.Autoantibodies against apolipoprotein A-1 and phosphorylcholine for diagnosis of non-ST-segment elevation myocardial infarction.Plasma CD93 concentration is a potential novel biomarker for coronary artery diseaseDiagnostic and prognostic value of autoantibodies anti-apolipoprotein A-1 and anti-phosphorylcholine in acute non-ST elevation myocardial infarction
P2860
Q28081863-DF0171E1-9BDE-4B64-B523-8D0D70F3E99CQ28390958-740338D7-3B05-4DD0-BA70-879F8576E6C4Q28658418-50D1C6FF-3F41-4EBC-923D-66DA9A1A348FQ28688590-333E99FA-D77A-49F3-BBFC-A5325F964F9AQ30547812-6C731556-37F6-4F25-9104-887EF777CCA9Q33590235-33992F25-3F9A-4C6B-B635-328C05B30173Q34230397-242211A0-0F92-4302-8F0A-53408B163869Q34275789-2F7BB189-952A-4243-AB9B-283C3FB3D28DQ34538210-8A247069-9942-416C-B485-5E341AE17622Q34613997-1CB7597F-F4CC-4B0D-9F10-9B90F212F0EFQ34662795-EC4A6654-68C9-4422-83C9-055C1C47E5F6Q35072824-01C8122E-B935-47F1-8E46-8E78560FCF3BQ35211633-566BB622-70BA-4B9A-A100-2155918AC3EFQ35557796-BA8C952C-EAC0-4829-9B0B-F8EC5D130B42Q35686658-DEA8EA90-3CB9-4002-9E29-9FEEC92246EBQ36253671-83F28ABF-0DB6-4122-A6E2-C7266356ED82Q36783414-4DC845EE-E82B-4A43-8AA4-CBBB99F60BA1Q36822711-0D0CF976-4018-424C-A3CB-F960631900ECQ37261617-C7176F25-C78E-4D42-A2DA-214398E9CF19Q37425498-8601A68D-3D61-475C-AE6D-52EAD53E26D8Q37556461-6599E202-DA0D-4CD4-992F-94080C3653D0Q37682418-54AAC73D-FCAB-41EA-ABDA-1166C0DF9F8DQ37824302-28BB361F-FC45-4234-8AF9-55DDEBA0583AQ37980498-6074A757-4AE6-40B6-AA6E-BFB44836CC35Q38090919-D431E401-B1E9-4833-85EB-61FF3AC4A6E8Q38291820-203530A9-E95A-4267-B2A2-ECBF4788EE70Q38491162-3C3434A0-03F4-4D14-B128-5C51A4CA289BQ40439971-04EF6D52-78BA-4645-B7C8-5DA2F3674AFAQ41844631-F1014A3E-ABB3-40BF-A55B-80B79AE1ABA0Q43077954-0BA9B4B2-AE38-4CF5-86A3-F22DA6C25EC8Q43089504-B37B546B-A118-418C-B97A-247D270C1FDAQ45354449-ED5D419F-3A5C-4962-B476-35CD49C253E0Q47623831-FCABB632-7A03-45ED-B9A3-35DF85EB50A1Q47661912-42350102-7834-442A-BD46-4BBA7CBA09C7Q47995027-15AC03B1-35F5-4E93-9A4E-4E16C3EC5167Q51503137-02A37B61-D742-4C3B-9960-FC9A0A86213DQ57393865-01A2C52D-C422-4F6E-8D85-8A9F957CEB06Q58197552-F46F4A51-0103-476E-841E-C73CB1914C53
P2860
Low levels of IgM antibodies to phosphorylcholine predict cardiovascular disease in 60-year old men: effects on uptake of oxidized LDL in macrophages as a potential mechanism.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Low levels of IgM antibodies t ...... ages as a potential mechanism.
@en
Low levels of IgM antibodies t ...... ages as a potential mechanism.
@nl
type
label
Low levels of IgM antibodies t ...... ages as a potential mechanism.
@en
Low levels of IgM antibodies t ...... ages as a potential mechanism.
@nl
prefLabel
Low levels of IgM antibodies t ...... ages as a potential mechanism.
@en
Low levels of IgM antibodies t ...... ages as a potential mechanism.
@nl
P2093
P921
P1476
Low levels of IgM antibodies t ...... ages as a potential mechanism.
@en
P2093
Anna Frostegård
Hans Grönlund
Ingrid Dahlbom
Johan Frostegård
Mats Halldin
Max Wikström
P356
10.1016/J.JAUT.2009.05.003
P577
2009-09-02T00:00:00Z